KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Change in Accured Expenses (2020 - 2025)

Boston Scientific (BSX) has disclosed Change in Accured Expenses for 6 consecutive years, with $285.0 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 25.97% to $285.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $296.0 million through Dec 2025, up 21.81% year-over-year, with the annual reading at $296.0 million for FY2025, 21.81% up from the prior year.
  • Change in Accured Expenses hit $285.0 million in Q4 2025 for Boston Scientific, up from $165.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $385.0 million in Q4 2024 to a low of -$450.0 million in Q1 2024.
  • Historically, Change in Accured Expenses has averaged $40.5 million across 5 years, with a median of $47.0 million in 2023.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 5357.14% in 2022 and later surged 1573.91% in 2024.
  • Year by year, Change in Accured Expenses stood at $133.0 million in 2021, then soared by 151.88% to $335.0 million in 2022, then tumbled by 93.13% to $23.0 million in 2023, then soared by 1573.91% to $385.0 million in 2024, then fell by 25.97% to $285.0 million in 2025.
  • Business Quant data shows Change in Accured Expenses for BSX at $285.0 million in Q4 2025, $165.0 million in Q3 2025, and $231.0 million in Q2 2025.